NCT01615419View on ClinicalTrials.gov

An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Rheumatoid Arthritis
Trial Locations (9)

11527

Athens

26443

Pátrai

54636

Thessaloniki

11 527

Athens

115 27

Athens

411 10

Larissa

265 04

Pátrai

851 00

Rhodes

546 42

Thessaloniki

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01615419 - An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter